Elting L - Search Results

1

Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients.

Jones P, Rolston K, Fainstein V, Elting L, Bodey GP. Jones P, et al. Among authors: elting l. Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S741-6. doi: 10.1093/clinids/7.supplement_4.s741. Rev Infect Dis. 1985. PMID: 3909332 Clinical Trial.

2

Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.

Rolston KV, Bodey GP, Elting L. Rolston KV, et al. Among authors: elting l. Am J Med. 1990 Mar 23;88(3C):24S-29S; discussion 38S-42S. doi: 10.1016/0002-9343(90)90084-q. Am J Med. 1990. PMID: 2180294 Review.

3

Aztreonam therapy in neutropenic patients with cancer.

Jones PG, Rolston KV, Fainstein V, Elting L, Walters RS, Bodey GP. Jones PG, et al. Among authors: elting l. Am J Med. 1986 Aug;81(2):243-8. doi: 10.1016/0002-9343(86)90258-5. Am J Med. 1986. PMID: 3526885 Clinical Trial.

4

A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.

Rolston KV, Nguyen H, Amos G, Elting L, Fainstein V, Bodey GP. Rolston KV, et al. Among authors: elting l. J Infect Dis. 1994 Feb;169(2):350-5. doi: 10.1093/infdis/169.2.350. J Infect Dis. 1994. PMID: 8106768 Clinical Trial.

5

Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital.

Bodey GP, Elting LS, Rodriguez S. Bodey GP, et al. Among authors: elting ls. Rev Infect Dis. 1991 Jul-Aug;13(4):550-8. doi: 10.1093/clinids/13.4.550. Rev Infect Dis. 1991. PMID: 1925270

6

Beta-lactam regimens for the febrile neutropenic patient.

Bodey GP, Fainstein V, Elting LS, Anaissie E, Rolston K, Khardori N, Kantarjian H, Plager C, Murphy WK, Holmes F, et al. Bodey GP, et al. Among authors: elting ls. Cancer. 1990 Jan 1;65(1):9-16. doi: 10.1002/1097-0142(19900101)65:1<9::aid-cncr2820650105>3.0.co;2-c. Cancer. 1990. PMID: 2403484 Clinical Trial.

7

Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials.

Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Elting LS, et al. Clin Infect Dis. 1997 Aug;25(2):247-59. doi: 10.1086/514550. Clin Infect Dis. 1997. PMID: 9332520

8

A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.

Rolston KV, Berkey P, Bodey GP, Anaissie EJ, Khardori NM, Joshi JH, Keating MJ, Holmes FA, Cabanillas FF, Elting L. Rolston KV, et al. Among authors: elting l. Arch Intern Med. 1992 Feb;152(2):283-91. Arch Intern Med. 1992. PMID: 1739355 Clinical Trial.

9

Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.

Bodey G, Reuben A, Elting L, Kantarjian H, Keating M, Hagemeister F, Koller C, Velasquez W, Papadopoulos N. Bodey G, et al. Among authors: elting l. Eur J Clin Microbiol Infect Dis. 1991 Jul;10(7):551-8. doi: 10.1007/BF01967272. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1915397 Clinical Trial.

10

Circadian variation in serum amikacin levels.

Elting L, Bodey GP, Rosenbaum B, Fainstein V. Elting L, et al. J Clin Pharmacol. 1990 Sep;30(9):798-801. doi: 10.1002/j.1552-4604.1990.tb01876.x. J Clin Pharmacol. 1990. PMID: 2277126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page